Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis. (Q39898245)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

apoptotic process

0 references

1 reference

based on heuristic

inferred from title

cell differentiation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Johnson Stanslas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Shiamala D Manikam

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

61

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

69-78

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Acute promyelocytic leukemia: a curable disease.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Acute promyelocytic leukemia: evolving therapeutic strategies

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Novel mutation in the PML/RARalpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in v

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Induction of differentiation and apoptosis- a possible strategy in the treatment of adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Immunostimulant agents from Andrographis paniculata.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Anticancer and immunostimulatory compounds from Andrographis paniculata

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Treatment of relapsed or refractory acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

The RXR heterodimers and orphan receptors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Cellular catabolism in apoptosis: DNA degradation and endonuclease activation.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Semisynthesis and cytotoxic activities of andrographolide analogues

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Semisynthesis and in vitro anticancer activities of andrographolide analogues.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0010

21 January 2018

Cell differentiation-inducing diterpenes from Andrographis paniculata Nees

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.42.1216

Identifiers

10.1211/JPP.61.01.0010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126299%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39898245&oldid=2132508932"